Original Investigation
Medicare Opioid Policy and Opioid Use in Beneficiaries With Disabilities
Hefei Wen, PhD; Alyssa Halbisen, MPH; Ann M. Thomas, PhD; et al.
Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes
Avik Ray, MD, MS; Julie M. Paik, MD, ScD, MPH; Deborah J. Wexler, MD, MSc; et al.
Editor's Note: Pleotropic Effects of Glucose-Lowering Medications—Need for Cautious Interpretation of Target Trial Emulation Studies ; Nathan M. Stall, MD, PhD; Timothy S. Anderson, MD, MAS; Kenneth E. Covinsky, MD, MPH
Editor's Note
Pleotropic Effects of Glucose-Lowering Medications—Need for Cautious Interpretation of Target Trial Emulation Studies
Nathan M. Stall, MD, PhD; Timothy S. Anderson, MD, MAS; Kenneth E. Covinsky, MD, MPH
Research Letter
Shareholder Payouts Among Large Publicly Traded Health Care Companies
Victor Roy, MD, PhD; Victor Amana, MPH; Joseph S. Ross, MD, MHS; et al.
Comment & Response
Complexity and Challenges of Measuring PrEP Adherence
David Garcia-Martinez, PharmD; Inés Soto-Baselga, PharmD, MSc; Noelia Garrido-Peño, PharmD, MSc
Editorial: Picking Up PrEP—Role of Clinician Specialty; Meredith Greene, MD; Lona Mody, MD, MSc
Complexity and Challenges of Measuring PrEP Adherence—Reply
Lorraine T. Dean, ScD
Editorial: Picking Up PrEP—Role of Clinician Specialty; Meredith Greene, MD; Lona Mody, MD, MSc
Errors From Incorrect Description of the Study Sample
Hyeun Ah Kang, PhD
Correction
Errors in Key Points, Abstract, Text, Figures, Table 2, and Supplement 1
|